Cycurion is trading $0.64 (-6.57%) down in pre-market after no fresh company-specific catalyst was identified for August 17, 2026.
- August 14 earnings beat expectations, with $3.8 million revenue and $(0.41) EPS versus consensus of $3.62 million and $(0.56).
- Nasdaq delisting hearing remains scheduled for August 20, 2026, creating unresolved listing risk.
- Broader indices are mixed-to-positive, offering no clear market-wide explanation.